Lacutamab in patients with mycosis fungoides: efficacy results according to updated lymph node classification in the TELLOMAK study

被引：0

作者：

Bagot, Martine ^{[1
]}

Kim, Youn H. ^{[2
]}

Ortiz-Romero, Pablo L. ^{[3
]}

Zinzani, Pier Luigi ^{[4
]}

Beylot-Barry, Marie ^{[5
]}

Dalle, Stephane ^{[6
]}

Jacobsen, Eric ^{[7
]}

Combalia, Andrea ^{[8
]}

Huen, Auris ^{[9
]}

Mehta-Shah, Neha ^{[10
]}

Khodadoust, Michael ^{[11
]}

Mehta, Amitkumar ^{[12
]}

Dereure, Olivier ^{[13
]}

Battistella, Maxime ^{[14
]}

Gru, Alejandro ^{[15
]}

Moins-Teisserenc, Helene ^{[16
]}

Viotti, Julien ^{[17
]}

Paiva, Christine ^{[17
]}

Boyer-Chammard, Agnes ^{[17
]}

Porcu, Pierluigi ^{[18
]}

机构：

[1] Univ Paris Cite, Dept Dermatol, Hop St Louis, Inserm U976, Paris, France

[2] Stanford Univ, Dept Dermatol, Multidisciplinary Cutaneous Lymphoma Program, Stanford, CA USA

[3] Univ Complutense, Hosp 12 Octubre, Sch Med, Dept Dermatol, Madrid, Spain

[4] Univ Bologna, Inst Hematol Seragnoli, Dept Hematol, Bologna, Italy

[5] Univ Bordeaux, Ctr Hosp Univ Bordeaux, Dept Dermatol, Inserm 1312, Bordeaux, France

[6] Hosp Civils Lyon, Dept Dermatol, Pierre Benite, France

[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[8] Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain

[9] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA

[10] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA

[11] Stanford Univ, Dept Med Oncol, Stanford, CA USA

[12] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA

[13] Univ Montpellier I, CHU Montpellier, Dept Dermatol, Montpellier, France

[14] Univ Paris Cite, Dept Pathol, Hop St Louis, Inserm U976, Paris, France

[15] Univ Virginia, Dept Pathol, Sch Med, Charlottesville, VA USA

[16] Univ Paris Cite, Hop St Louis, AP HP, Hematol Lab,INSERM U976, Paris, France

[17] Innate Pharma, Clin Dev, Marseille, France

[18] Thomas Jefferson Univ, Jefferson Hlth, Sidney Kimmel Canc Ctr, Department Med Oncol, Philadelphia, PA USA

来源：

EUROPEAN JOURNAL OF CANCER | 2023年 / 190卷

关键词：

D O I：

10.1016/j.ejca.2023.113032

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O-144

引用

页码：S19 / S20

页数：2

共 50 条

[1] Lacutamab in patients with relapsed and/or refractory mycosis fungoides: results from the TELLOMAK phase 2 trial
Porcu, P.
Bagot, M.
Ram-Wolff, C.
Huen, A. O.
Dalle, S.
Poligone, B.
Mehta-Shah, N.
Duval-Modeste, A. -B.
Zinzani, P. L.
Woei-A-Jin, S.
Eigentler, T.
Combalia, A.
Sokol, L.
Battistella, M.
Gru, A.
Moins-Teisserenc, H.
Viotti, J.
Paiva, C.
Boyer-Chammard, A.
Kim, Y. -H.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S27
[2] Lacutamab in patients with relapsed and/or refractory mycosis fungoides: Results from the TELLOMAK phase 2 trial.
Porcu, Pierluigi
Bagot, Martine
Ram-Wolff, Caroline
Kim, Youn H.
Huen, Auris
Dalle, Stephane
Poligone, Brian
Mehta-Shah, Neha
Modeste, Anne Benedicte Duval
Zinzani, Pier Luigi
Woei-A-Jin, Feng Jung Sherida Harriette
Eigentler, Thomas
Combalia, Andrea
Sokol, Lubomir
Battistella, Maxime
Gru, Alejandro
Teisserenc, Helene Moins
Viotti, Julien
Paiva, Christine
Chammard, Agnes Boyer
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[3] Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
Bagot, M.
Muller, M.
Kim, Y. H.
Ortiz-Romero, P. L.
Zinzani, P. L.
Beylot-Barry, M.
Dalle, S.
Jacobsen, E.
Combalia, A.
Huen, A.
Mehta-Shah, N.
Khodadoust, M. S.
Viotti, J.
Paiva, C.
Porcu, P.
EUROPEAN JOURNAL OF CANCER, 2022, 173 : S20 - S21
[4] Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
Bagot, Martine
Kim, Youn
Zinzani, Pier Luigi
Dalle, Stephane
Beylot-Barry, Marie
Ortiz-Romero, Pablo L.
Cambalia, Andrea
Dereure, Olivier
Mortier, Laurent
Jacobsen, Eric
Battistella, Maxime
Gru, Alejandro
Moins-Teisserenc, Helene
Paiva, Christine
Boyer-Chammard, Agnes
Rotolo, Federico
Azim, Hatem A.
Porcu, Pierluigi
EUROPEAN JOURNAL OF CANCER, 2021, 156 : S20 - S21
[5] Lymph node infiltration in mycosis fungoides and Sezary syndrome: ultrasound features descriptive study
Gonzalez Mendez, V.
Merina, A.
Mitsunaga, K.
Barcena, C.
Martin Arriscado, C.
Ortiz-Romero, P. L.
EUROPEAN JOURNAL OF CANCER, 2022, 173 : S14 - S14
[6] DNA-CYTOPHOTOMETRY OF LYMPH-NODE IMPRINTS FROM PATIENTS WITH MYCOSIS-FUNGOIDES
VANVLOTEN, WA
SCHEFFER, E
MEIJER, CJLM
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1979, 73 (04) : 275 - 277
[7] SYSTEMIC POLYCHEMOTHERAPY IN PATIENTS WITH MYCOSIS-FUNGOIDES AND LYMPH-NODE INVOLVEMENT - A FOLLOW-UP-STUDY OF 17 PATIENTS
SENTIS, HJ
WILLEMZE, R
VANVLOTEN, WA
ACTA DERMATO-VENEREOLOGICA, 1985, 65 (02) : 179 - 183
[8] Efficacy and safety of methotrexate in the treatment of mycosis fungoides: results from a multicenter study
Panou, Evdoxia
Tsimpidakis, Antonis
Papadavid, Evangelia
Patsatsi, Aikaterini
Siakantaris, Marina
Kruger-Krasagakis, Sabine
Marinos, Leonidas
Georgiou, Elissavet
Lampadaki, Kyriaki
Velissari, Aliki
Daponte, Athina-Ioanna
Aikaterini, Doxastaki
Kalliampou, Stela
Vaiopoulos, Aristidiis
Konstandinou, Ilianna
Koumourtzis, Marios
Lakiotaki, Eleftheria
Pappa, Vasiliki
Stratigos, Alaexandros
Nikolaou, Vasiliki
EUROPEAN JOURNAL OF CANCER, 2023, 190 : S41 - S41
[9] Pembrolizumab in mycosis fungoides and Sezary syndrome: Updated results of the CITN multicenter Phase 2 study
Khodadoust, Michael S.
Rook, Alain H.
Porcu, Pierluigi
Foss, Francine
Moskowitz, Alison
Shustov, Andrei R.
Shanbhag, Satish
Sokol, Lubomir
Fling, Steven P.
Li, Shufeng
Fong, Sophia
Kim, Jinah
Yang, Yi
Yearley, Jennifer
Subrahmanyam, Priyanka
Maecker, Holden
Horwitz, Steven M.
Sharon, Elad
Cheever, Martin A.
Kim, Youn H.
EUROPEAN JOURNAL OF CANCER, 2018, 101 : S37 - S37
[10] Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides: Results from the MAVORIC study.
Geskin, Larisa J.
Scarisbrick, Julia
Bagot, Martine
Fisher, David Christopher
Elmets, Craig
Duvic, Madeleine
Beylot-Barry, Marie
Kim, Ellen J.
Moriya, Junji
Leoni, Mollie
Zinzani, Pier Luigi
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

← 1 2 3 4 5 →